MYADM anticorps (AA 51-150) (Biotin)

N° du produit ABIN6944174

Détail du produit anti-MYADM anticorps (Biotin)

Antigène: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Épitope: AA 51-150

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MYADM est conjugé à/à la Biotin

Application: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))

Specificité: This antibody's immunogen sequence has 91 % homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples

Réactivité croisée: Humain

Homologie: Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MYADM

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur MYADM

Antigène: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Autre désignation: MYADM (MYADM Produits)

Synonymes: anticorps myadm, anticorps MGC79604, anticorps MYADM, anticorps MGC140812, anticorps SB135, anticorps D7Wsu62e, anticorps myeloid-associated differentiation marker, anticorps myeloid associated differentiation marker, anticorps myadm, anticorps MYADM, anticorps Myadm

Sujet:

Synonyms: MYADM, MYADM_HUMAN, myeloid associated differentiation marker, Myeloid upregulated protein, Myeloid-associated differentiation marker, Protein SB135.

Background: Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions.

ID gène: 91663

UniProt: Q96S97